Dr. Bernadette Melnyk, PhD
Claim this profileStudies Anxiety Disorders
Studies Depression
1 reported clinical trial
1 drug studied
More about Bernadette Melnyk, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Bernadette Melnyk, PhD has experience with
- COPE-P
Breakdown of trials Bernadette Melnyk, PhD has run
Postpartum Depression
Gastrointestinal Discomfort
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bernadette Melnyk, PhD specialize in?
Bernadette Melnyk, PhD focuses on Anxiety Disorders and Depression. In particular, much of their work with Anxiety Disorders has involved treating patients, or patients who are undergoing treatment.
Is Bernadette Melnyk, PhD currently recruiting for clinical trials?
No, Bernadette Melnyk, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Bernadette Melnyk, PhD has studied deeply?
Yes, Bernadette Melnyk, PhD has studied treatments such as COPE-P.
What is the best way to schedule an appointment with Bernadette Melnyk, PhD?
Apply for one of the trials that Bernadette Melnyk, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.